Sickle Cell Disease - Market Insights, Epidemiology and Market Forecast - 2025

Tuesday, October 24, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 23, 2017 /PRNewswire/ -- DelveInsight's "Sickle Cell Disease (SCD) – Market Insights, Epidemiology and Market Forecast-2025" report provides an overview of Sickle Cell Disease, epidemiology and market trend of the Sickle Cell Disease for the United States and EU5 (Germany, Spain, Italy, France and United Kingdom).

Download the full report: Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Sickle Cell Disease from 2017 to 2025 segmented by seven major
markets. In addition, the report also includes the forecasted epidemiology of Sickle Cell Disease till 2025.The Report also covers market drivers, market barriers and unmet medical need. According to DelveInsight, the prevalent population of Sickle Cell Disease is expected to reach up to XXX cases by the end of 2025 at a CAGR of 0.85% from 2015-2025 in 6MM (excluding Japan). High prevalent cases were observed in United States as compared to EU5. The higher prevalence of Sickle Cell Disease in United States is attributed to the immigration of majority of African population in the United States. Greater uptake by the three emerging novel drugs Endari (Emmaus Lifesciences), GBT-440 (GBT Therapeutics), and Crizanlizumab (Novartis) will primarily drive the SCD market. As the number of effective treatments for the Sickle Cell Disease increase in the market during the forecast period, the prescription medications (HU; Iron Chelators, Analegesics, Antibiotics, vaccines) market share will start to decrease. Emmaus's Endari will be the preferred therapy for the complications associated with SCD owing to its less cost, which will give more patient access to this therapy. United States contributes the major share of Sickle Cell Disease market as compared to EU5 countries. The therapeutic market of Sickle Cell Disease in 6MM is expected to reach USD 3.1 Billion in 2025 at the CAGR of XX% from 2015-2025. Key Coverage and Benefits: • The report will help in developing business strategies by understanding the trends shaping and driving the global Sickle Cell Disease market. • Organize sales and marketing efforts by identifying the best opportunities for Sickle Cell Disease in US and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom). • To understand the future market competition in the Sickle Cell Disease market and Insightful review of the key market drivers and barriers. • The report provides historical as well as forecasted epidemiology of Sickle Cell Disease in the 6MM covering United States and EU5 (Germany, Spain, Italy, France and United Kingdom) from 2015-2025. • The Report also covers the detailed historical and forecasted Sickle Cell Disease market covering United States and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) from 2015-2025.Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store